Calming sterile inflammation in intervertebral disc degeneration: taurine disrupts mitochondria-cGAS-STING signaling via autophagy enhancement

Shuangjia Zai , Huofeng Wu , Xuan You , Chen Liu , Zhaoyu Li , Benkui Hua , Chengyu Hou , Zhengguang Li , Liang Zhang

Precision Clinical Medicine ›› 2026, Vol. 9 ›› Issue (2) : pbag013

PDF (5045KB)
Precision Clinical Medicine ›› 2026, Vol. 9 ›› Issue (2) :pbag013 DOI: 10.1093/pcmedi/pbag013
Research article
research-article
Calming sterile inflammation in intervertebral disc degeneration: taurine disrupts mitochondria-cGAS-STING signaling via autophagy enhancement
Author information +
History +
PDF (5045KB)

Abstract

Background: Intervertebral disc degeneration (IVDD) is a major pathological process leading to low back pain, closely associated with the functional decline of nucleus pulposus progenitor cell (NPPC). The role of the cGAS-STING pathway in mediating DNA-sensing-associated inflammation and senescence in IVDD has not been fully elucidated.

Methods: This study integrated genetics, computational biology, cellular experiments, and animal models to systematically investigate whether taurine (TAU) exerts protective effects by modulating this pathway.

Results: Mendelian randomization analysis suggested a causal relationship between higher TAU levels and reduced risk of IVDD. Molecular docking and dynamics simulations demonstrated that TAU stably binds to cGAS and STING. In both degenerated human nucleus pulposus (NP) tissues and an H2O2-induced NPPC senescence model, the cGAS-STING pathway was significantly activated. TAU intervention maintained mitochondrial function, reduced cytosolic mtDNA leakage, and enhanced autophagic degradation of STING, thereby suppressing downstream TBK1-IRF3/NLRP3 inflammatory signaling and subsequently alleviating cellular senescence, inflammatory responses, and apoptosis. TAU treatment effectively delayed intervertebral disc height loss, histopathological progression, and pain sensitivity in a rat IVDD model.

Conclusion: This study is the first to reveal that TAU mitigates IVDD through multi-targeted modulation of the “mitochondria-cGAS-STING” axis, providing a theoretical foundation for its translational application as a disease-modifying agent.

Keywords

taurine / intervertebral disc degeneration / STING / mitochondria / nucleus pulposus progenitor cell

Cite this article

Download citation ▾
Shuangjia Zai, Huofeng Wu, Xuan You, Chen Liu, Zhaoyu Li, Benkui Hua, Chengyu Hou, Zhengguang Li, Liang Zhang. Calming sterile inflammation in intervertebral disc degeneration: taurine disrupts mitochondria-cGAS-STING signaling via autophagy enhancement. Precision Clinical Medicine, 2026, 9 (2) : pbag013 DOI:10.1093/pcmedi/pbag013

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Zhan J, Cui Y, Zhang P et al. Cartilage endplate-targeted engineered exosome releasing and acid neutralizing hydrogel reverses intervertebral disc degeneration. Adv Healthc Mater 2025; 14:2403315. https://doi.org/10.1002/adhm.202403315

[2]

Zhu D, Wang Z, Chen S et al. Therapeutic potential of targeting the IRF2/POSTN/Notch1 axis in nucleus pulposus cells for intervertebral disc degeneration. J Neuroinflammation 2025; 22:13. https://doi.org/10.1186/s12974-025-03335-4

[3]

Zhang W, Li G, Zhou X et al. Disassembly of the TRIM56-ATR complex promotes cytoDNA/cGAS/STING axisdependent intervertebral disc inflammatory degeneration. J Clin Invest 2024; 134:e165140. https://doi.org/10.1172/JCI165140.

[4]

Jing X, Wang W, He X et al. HIF-2alpha/TFR1 mediated iron homeostasis disruption aggravates cartilage endplate degeneration through ferroptotic damage and mtDNA release: a new mechanism of intervertebral disc degeneration. J Orthop Transl 2024; 46:65-78. https://doi.org/10.1016/j.jot.2024.03.005

[5]

Wang W, Cheng Z, Yu M et al. Injectable ECM-mimetic dynamic hydrogels abolish ferroptosis-induced post-discectomy herniation through delivering nucleus pulposus progenitor cellderived exosomes. Nat Commun 2025; 16:3131. https://doi.org/10.1038/s41467-025-58447-5

[6]

Chen Y, Zhang L, Shi X et al. Characterization of the nucleus pulposus progenitor cells via spatial transcriptomics. Adv Sci 2024; 11:e2303752. https://doi.org/10.1002/advs.202303752

[7]

Zhao D-W, Zhang J, Chen C et al. Rejuvenation modulation of nucleus pulposus progenitor cells reverses senescenceassociated intervertebral disc degeneration. Adv Mater 2025; 37:2409979. https://doi.org/10.1002/adma.202409979

[8]

Chen Z, Chen C, Yang X et al. Dysfunction of STING autophagy degradation in senescent nucleus pulposus cells accelerates intervertebral disc degeneration. Int J Biol Sci 2024; 20:2370-87. https://doi.org/10.7150/ijbs.88534

[9]

Zheng J, Ma Z, Liu P et al. EZH2 inhibits senescenceassociated inflammation and attenuates intervertebral disc degeneration by regulating the cGAS/STING pathway via H3K27me3. Osteoarthritis Cartil 2025; 33:548-59. https://doi.org/10.1016/j.joca.2025.02.771

[10]

Guo Q, Zhu D, Wang Y et al. Targeting STING attenuates ROS induced intervertebral disc degeneration. Osteoarthritis Cartil 2021; 29:1213-24. https://doi.org/10.1016/j.joca.2021.04.017

[11]

Ren C, Jin J, Li C et al. Metformin inactivates the cGAS-STING pathway through autophagy and suppresses senescence in nucleus pulposus cells. J Cell Sci 2022; 135:jcs259738. https://doi.org/10.1242/jcs.259738.

[12]

Luo L, Zhang S, Gong J et al. 3-D sustained-release culture carrier alleviates rat intervertebral disc degeneration by targeting STING in transplanted skeletal stem cells. Adv Sci 2025; 12:e2410151. https://doi.org/10.1002/advs.202410151

[13]

Lin S, Li T, Zhang B et al. Taurine rescues intervertebral disc degeneration by activating mitophagy through the PINK1/Parkin pathway. Biochem Biophys Res Commun 2024; 739:150587. https://doi.org/10.1016/j.bbrc.2024.150587

[14]

Yang L, Li Z, Ouyang Y. Taurine attenuates ER stress- associated apoptosis and catabolism in nucleus pulposus cells. Mol Med Rep 2022; 25:172. https://doi.org/10.3892/mmr.2022.12688.

[15]

Tsuboi A, Khanom H, Kawabata R et al. Taurine ameliorates cellular senescence associated with an increased hydrogen sulfide and a decreased hepatokine, IGFBP-1, in CCl4-induced hepatotoxicity in mice. Redox Biol 2025; 83:103640. https://doi.org/10.1016/j.redox.2025.103640

[16]

Cao T, Zhang W, Wang Q et al. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8( + ) T cells. Cell 2024; 187:2288-2304.e27. https://doi.org/10.1016/j.cell.2024.03.011

[17]

Fernandez ME, Bernier M, Price NL et al. Is taurine an aging biomarker?. Science 2025; 388:eadl2116. https://doi.org/10.1126/science.adl2116

[18]

Pfirrmann CWA, Metzdorf A, Zanetti M et al. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976) 2001; 26:1873-8.

[19]

Jo S, Kim T, Iyer VG et al. CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem 2008; 29:1859-65. https://doi.org/10.1002/jcc.20945

[20]

Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPCE water models at 298 K. J Phys Chem A 2001; 105:9954-60. https://doi.org/10.1021/jp003020w

[21]

Greco MFD, Minelli C, Sheehan NA et al. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med 2015; 34: 2926-40.

[22]

Ye Y, Wan L, Hu J et al. Combined single-cell RNA sequencing and mendelian randomization to identify biomarkers associated with necrotic apoptosis in intervertebral disc degeneration. Spine J 2025; 25:165-83. https://doi.org/10.1016/j.spinee.2024.09.011

[23]

Zheng YP, Yang DL, Wang LY et al. Causal relationship between gut microbiota, blood metabolites, and intervertebral disc degeneration: a two-step, two-sample bidirectional Mendelian randomization study. Jor Spine 2025; 8:e70078. https://doi.org/10.1002/jsp2.70078.

[24]

Yan XA, Shen E, Cui A et al. Assessing the causal relationship between CRP, IL-1alpha, IL-1beta, and IL-6 levels and intervertebral disc degeneration: a two-sample Mendelian randomization study. Sci Rep 2024; 14:23716. https://doi.org/10.1038/s41598-024-73205-1

[25]

Liu L, Zeng P, Xue F et al. Multi-trait transcriptome-wide association studies with probabilistic Mendelian randomization. Am Hum Genet 2021; 108:240-56. https://doi.org/10.1016/j.ajhg.2020.12.006

[26]

Peng S, Liu X, Chang L et al. Exosomes derived from rejuvenated stem cells inactivate NLRP3 inflammasome and pyroptosis of nucleus pulposus cells via the transfer of antioxidants. Tissue Eng Regen Med 2024; 21:1061-77. https://doi.org/10.1007/s13770-024-00663-z

[27]

Liu Y, Li Y, Huang ZN et al. The effec t of intervertebral disc degenerative change on biological characteristics of nucleus pulposus mesenchymal stem cell: an in vitro study in rats. Connect Tissue Res 2019; 60:376-88. https://doi.org/10.1080/03008207.2019.1570168

[28]

Zhao WJ, Liu X, Hu M et al. Quercetin ameliorates oxidative stress-induced senescence in rat nucleus pulposus-derived mesenchymal stem cells via the miR-34a-5p/SIRT1 axis. World J Stem Cells 2023; 15:842-65. https://doi.org/10.4252/wjsc.v15.i8.842

[29]

Zhang Y, Yang S, You X et al. CircSPG21 ameliorates oxidative stress-induced senescence in nucleus pulposus-derived mesenchymal stem cells and mitigates intervertebral disc degeneration through the miR-217/SIRT1 axis and mitophagy. Stem Cell Res Ther 2025; 16:49. https://doi.org/10.1186/s13287-025-04180-1

[30]

Norcross JP, Lester GE, Weinhold P et al. An in vivo model of degenerative disc disease. J Orthop Res 2003; 21:183-8. https://doi.org/10.1016/S0736-0266(02)00098-0

[31]

Wang JW, Zhu L, Shi PZ et al. 1,25(OH)(2)D(3) mitigates oxidative stress-induced damage to nucleus pulposus-derived mesenchymal stem cells through PI3K/Akt pathway. Oxid Med Cell Long 2022; 2022:1427110. https://doi.org/10.1155/2022/1427110

[32]

Shi PZ, Wang JW, Wang PC et al. Urolithin a alleviates oxidative stress-induced senescence in nucleus pulposus-derived mesenchymal stem cells through SIRT1/PGC-1alpha pathway. WJSC 2021; 13:1928-46. https://doi.org/10.4252/wjsc.v13.i12.1928

[33]

Nan LP, Wang F, Ran D et al. Naringin alleviates H(2)O(2)-induced apoptosis via the PI3K/Akt pathway in rat nucleus pulposus-derived mesenchymal stem cells. Connect Tissue Res 2020; 61:554-67. https://doi.org/10.1080/03008207.2019.1631299

[34]

Xu Y, Zhang L, Ji M et al. Prominin-2/FBXO22/BACH1 axis protects bone marrow mesenchymal stem cells against TBHPinduced ferroptosis and ameliorates intervertebral disc degeneration. Stem Cell Res Ther 2025; 16:340. https://doi.org/10.1186/s13287-025-04453-9

[35]

Wang L, Wang Y, Jiao J et al. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles carrying microRNAs for modulating autophagy and cellular degeneration in intervertebral disc degeneration. Spine (Phila Pa 1976) 2025; 50:E7-E19.

[36]

Zheng B, Zhang X, Kong X et al. S1P regulates intervertebral disc aging by mediating endoplasmic reticulummitochondrial calcium ion homeostasis. JCI Insight 2024; 9:e177789. https://doi.org/10.1172/jci.insight.177789.

[37]

Zhang W, Li G, Luo R et al. Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis. Exp Mol Med 2022; 54:129-42. https://doi.org/10.1038/s12276-022-00729-9

[38]

Cui X, Zhang F, Cui D et al. TBRG4 regulates ubiquitination of Beclin1 and participates in autophagy pathway to inhibit intervertebral disc degeneration. Spine J 2025; 25:2569-84. https://doi.org/10.1016/j.spinee.2025.05.018

[39]

Sang P, Ma Y, Zhang X et al. BMAL1 attenuates intervertebral disc degeneration by activating the SIRT1/PGC-1alpha pathway: evidence from vitro studies. Sci Rep 2025; 15:9651. https://doi.org/10.1038/s41598-025-94029-7

[40]

Yang G, Dong C, Wu Z et al. Single-cell RNA sequencing-guided engineering of mitochondrial therapies for intervertebral disc degeneration by regulating mtDNA/SPARC-STING signaling. Bioact Mater 2025; 48:564-82. https://doi.org/10.1016/j.bioactmat.2025.02.036

[41]

Wang P, Zhang S, Liu W et al. Bardoxolone methyl breaks the vicious cycle between M1 macrophages and senescent nucleus pulposus cells through the Nrf2/STING/NF-kappaB pathway. Int Immunopharmacol 2024; 127:111262. https://doi.org/10.1016/j.intimp.2023.111262

PDF (5045KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/